Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models
Christina A. Wicker, Brian G. Hunt, Sunil Krishnan, Kathryn E. Aziz, Shobha Parajuli, Sarah Palackdharry, William R. Elaban, Trisha M. Wise‐Draper, Gordon B. Mills, Susan E. Waltz, Vinita Takiar
Topics & Concepts
RadioresistanceHead and neck squamous-cell carcinomaCancer researchGlutaminaseIonizing radiationGlutamineHead and neck cancerRadiation therapyCell cultureCancerChemistryMedicineInternal medicineBiologyIrradiationBiochemistryAmino acidPhysicsNuclear physicsGeneticsCancer, Hypoxia, and MetabolismGenomics, phytochemicals, and oxidative stressRNA modifications and cancer